Terms ending in 2031
Rapid Pathogen Screening, Inc.
Every in-force patent on Rapid Pathogen Screening, Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,002,734 | Methods and Devices for Using Mucolytic Agents Including N-Acetyl Cysteine (NAC) In force · High confidence | Rapid Pathogen Screening, Inc. | In force | High confidence | |
| US 8,470,608 | Combined Visual/Fluorescence Analyte Detection Test In force · High confidence | Rapid Pathogen Screening, Inc. | In force | High confidence | |
| US 8,614,101 | In Situ Lysis of Cells in Lateral Flow Immunoassays In force · High confidence | Rapid Pathogen Screening, Inc. | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.